Jiangsu Apon Medical Technology Co., Ltd. (SHE:300753)
China flag China · Delayed Price · Currency is CNY
20.37
+0.36 (1.80%)
Sep 14, 2026, 3:04 PM CST

SHE:300753 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
328.89339.37402.3420.79323.38460.72
Other Revenue
2.722.651.51.380.430.49
331.61342.02403.8422.17323.81461.21
Revenue Growth
-13.53%-15.30%-4.35%30.38%-29.79%4.09%
Cost of Revenue
103.24110.4127.74145.71163.82166.33
Gross Profit
228.37231.62276.06276.46159.99294.88
Selling, General & Admin
214.85227.85231.61228.59207.17199.73
Research & Development
41.6140.5633.2836.5534.9543.98
Other Operating Expenses
-1.18-4.73-13.03-8.28-2.53-3.78
Operating Expenses
244.43261.15258.06264.8240.71246.76
Operating Income
-16.06-29.531811.66-80.7248.12
Interest Expense
-2.99-3.26-3.07-3.04-2.47-1.13
Interest & Investment Income
0.552.041.982.273.514.46
Currency Exchange Gain (Loss)
-0-00---
Other Non Operating Income (Expenses)
0.45-0.06-0.06-0.06-0.06-0.1
EBT Excluding Unusual Items
-18.05-30.8116.8610.84-79.7551.35
Impairment of Goodwill
-----16.16-
Gain (Loss) on Sale of Investments
-0.73--1.38-1.44--
Gain (Loss) on Sale of Assets
0.110.123.590.01-0.02-
Asset Writedown
-0.04-0.03-0-0-0.01-0
Other Unusual Items
34.632.114.415.243.95
Pretax Income
-15.71-26.0821.1713.81-90.7155.3
Income Tax Expense
3.030.7510.275.36-14.591.98
Earnings From Continuing Operations
-18.74-26.8310.898.45-76.1253.32
Minority Interest in Earnings
4.212.81-0.09-0.170.140.75
Net Income
-14.53-24.0210.88.28-75.9854.06
Net Income to Common
-14.53-24.0210.88.28-75.9854.06
Net Income Growth
--30.48%---44.24%
Shares Outstanding (Basic)
126126126126126126
Shares Outstanding (Diluted)
126126126126126126
Shares Change
-0.05%-0.00%0.03%-0.05%-0.00%0.00%
EPS (Basic)
-0.12-0.190.090.07-0.600.43
EPS (Diluted)
-0.12-0.190.090.07-0.600.43
EPS Growth
--30.44%---44.24%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
29.69-6.15.45-54.07-48.76-21.31
Free Cash Flow Per Share
0.24-0.050.04-0.43-0.39-0.17
Dividend Per Share
--0.0650.065--
Dividend Growth
--0%-74.00%--
Gross Margin
68.87%67.72%68.37%65.49%49.41%63.94%
Operating Margin
-4.84%-8.63%4.46%2.76%-24.93%10.43%
Profit Margin
-4.38%-7.02%2.67%1.96%-23.46%11.72%
Free Cash Flow Margin
8.95%-1.78%1.35%-12.81%-15.06%-4.62%
EBITDA
-1.77-15.6733.0224.33-66.9760.9
EBITDA Margin
-0.53%-4.58%8.18%5.76%-20.68%13.21%
D&A For EBITDA
14.2913.8615.0212.6713.7612.78
EBIT
-16.06-29.531811.66-80.7248.12
EBIT Margin
-4.84%-8.63%4.46%2.76%-24.93%10.43%
Effective Tax Rate
--48.53%38.81%-3.58%
Revenue as Reported
331.61342.02403.8422.17323.81461.21
Advertising Expenses
-25.6924.3431.3527.2816.48